Section Arrow
ABBV.NYSE
- ABBVIE
Quotes are at least 15-min delayed:2026/04/25 04:13 EDT
Regular Hours
Last
 198.71
-2.24 (-1.11%)
Day High 
200.245 
Prev. Close
200.95 
1-M High
220.45 
Volume 
7.61M 
Bid
198.31
Ask
198.71
Day Low
197.14 
Open
198.93 
1-M Low
199.81 
Market Cap 
355.43B 
Currency 美元 
P/E 84.84 
%Yield 3.39 
10-SMA 206.07 
20-SMA 208.64 
50-SMA 217.54 
52-W High 244.81 
52-W Low 176.57 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
2.37/16.16
Enterprise Value
414.37B
Balance Sheet
Book Value Per Share
-1.85
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
61.16B
Operating Revenue Per Share
31.17
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFEPfizer27+0.33+1.24%19.61PE
OGNOrganon & Co11.26+2.66+30.93%11.87PE
NVONovo-Nordisk A/S41.17+2.65+6.88%10.72PE
ABBVABBVIE198.71-2.24-1.11%84.84PE
MRKMerck & Co111.9-2.72-2.37%15.67PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan addedseveral new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.